Healthcare provider profile · identity verified

Patrick Robert Dennison, D.O.

Family Practice · GARFIELD HEIGHTS, OH · NPI 1235370461

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	122	39
Atorvastatin Calcium	Atorvastatin Calcium	110	38
Gabapentin	Gabapentin	110	26
Omeprazole	Omeprazole	100	35
Tramadol Hcl	Tramadol Hcl	100	27
Rosuvastatin Calcium	Rosuvastatin Calcium	93	36
Lisinopril	Lisinopril	89	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	82	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	81	16
Amlodipine Besylate	Amlodipine Besylate	76	29
Furosemide	Furosemide	72	25
Ibuprofen	Ibuprofen	68	17
Atenolol	Atenolol	66	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	19
Alprazolam	Alprazolam	63	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	62	19
Eliquis	Apixaban	62	20
Pantoprazole Sodium	Pantoprazole Sodium	58	21
Metformin Hcl	Metformin Hcl	56	24
Lorazepam	Lorazepam	49	15
Losartan Potassium	Losartan Potassium	47	17
Hydrochlorothiazide	Hydrochlorothiazide	46	14
Ozempic	Semaglutide	46	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	42	13
Alendronate Sodium	Alendronate Sodium	40	16
Simvastatin	Simvastatin	40	12
Meloxicam	Meloxicam	39	17
Tizanidine Hcl	Tizanidine Hcl	38	15
Trazodone Hcl	Trazodone Hcl	36	12
Metoprolol Succinate	Metoprolol Succinate	35	11
Pregabalin	Pregabalin	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	13
Farxiga	Dapagliflozin Propanediol	33	suppressed
Allopurinol	Allopurinol	32	11
Duloxetine Hcl	Duloxetine Hcl	32	12
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Potassium Chloride	Potassium Chloride	30	15
Montelukast Sodium	Montelukast Sodium	29	suppressed
Jardiance	Empagliflozin	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	13
Cephalexin	Cephalexin	25	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Valsartan	Valsartan	24	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Famotidine	Famotidine	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	21	11
Mirtazapine	Mirtazapine	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Methylprednisolone	Methylprednisolone	19	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	15
Trulicity	Dulaglutide	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Edarbi	Azilsartan Medoxomil	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Naproxen	Naproxen	16	suppressed
Nystatin	Nystatin	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Lidocaine	Lidocaine	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Diazepam	Diazepam	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error